Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2575735 | The American Journal of Geriatric Pharmacotherapy | 2012 | 14 Pages |
Abstract
The similar and low rates of AEs in DSG-treated patients aged â¥65 years and <65 years and in those with and without comorbid hypertension, type 2 diabetes, or cerebrovascular or cardiovascular disease suggest that DSG treatment is generally well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Geriatrics and Gerontology
Authors
Herbert S.B. MD, Morris S. ScD, Richard A. PharmD, Matthew S. MD,